2-aminobenzothiazoles as CB1 receptor inverse agonists

Details for Australian Patent Application No. 2004251002 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Roever, Stephan; Nettekoven, Matthias Heinrich

Agent Spruson & Ferguson

Pub. Number AU-B-2004251002

PCT Pub. Number WO2005/000301

Priority 03013403.5 20.06.03 EP

Filing date 11 June 2004

Wipo publication date 6 January 2005

Acceptance publication date 29 October 2009

International Classifications

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

C07D 277/82 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2005/000301 Priority application(s): WO2005/000301

29 October 2009 Application Accepted

  Published as AU-B-2004251002

25 February 2010 Standard Patent Sealed

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251003-Tablets containing enrofloxacin and flavouring agents and/or flavours

2004250998-Antigen-containing microspheres for the treatment of allergies